OWC Pharmaceutical Research (OWC Pharmaceutical Research) Total Stockholders Equity : $-4.01 Mil (As of Sep. 2019)

View and export this data going back to 2008. Start your Free Trial

What is OWC Pharmaceutical Research Total Stockholders Equity?

OWC Pharmaceutical Research's Total Stockholders Equity for the quarter that ended in Sep. 2019 was $-4.01 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. OWC Pharmaceutical Research's Book Value per Share for the quarter that ended in Sep. 2019 was $-0.02. The ratio of a company's debt over equity can be used to measure how leveraged this company is. OWC Pharmaceutical Research's Debt-to-Equity for the quarter that ended in Sep. 2019 was -0.01.

OWC Pharmaceutical Research Total Stockholders Equity Historical Data

The historical data trend for OWC Pharmaceutical Research's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OWC Pharmaceutical Research Total Stockholders Equity Chart

OWC Pharmaceutical Research Annual Data

Trend

Dec08

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Total Stockholders Equity

Get a 7-Day Free Trial

1.46

0.32

0.10

0.79

-9.44

OWC Pharmaceutical Research Quarterly Data
	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
Total Stockholders Equity	Get a 7-Day Free Trial															-3.79	-9.44	-10.24	-3.04	-4.01

OWC Pharmaceutical Research (OTCPK:OWCP) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

OWC Pharmaceutical Research's Book Value per Share for the quarter that ended in Sep. 2019 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-4.008	-	0)	/	244.478
	=	-0.02

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

OWC Pharmaceutical Research's Debt-to-Equity for the quarter that ended in Sep. 2019 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.026	+	0.021)	/	-4.008
	=	-0.01

OWC Pharmaceutical Research Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of OWC Pharmaceutical Research's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

OWC Pharmaceutical Research (OWC Pharmaceutical Research) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » OWC Pharmaceutical Research Corp (OTCPK:OWCP) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

2 Ben Gurion Street, Ramat Gan, ISR, 5257334

Website

http://www.owcpharma.com

OWC Pharmaceutical Research Corp is a medical cannabis research and development company. The firm through its subsidiary researches and develops cannabis-based products and treatments specifically designed for multiple myeloma, psoriasis, fibromyalgia, post-traumatic stress disorder (PTSD), migraine, sexual function and skin disorders. It also provides consulting services to governmental and private entities to assist them with developing and implementing tailor-made medical cannabis program.

Executives

Asher Zwebner

director, officer: CHIEF FINANCIAL OFFICER

CDOOR CORPORATION, 20 A REHOV SHAREI TORAH BAYIT VEGAN, JERUSALEM L3 96387